TherapeuticsMD inc (NYSE:TXMD) currently has a “Sell” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Sell” signal. 10 – 8 Day Moving Average Hilo Channel shows “Hold” signal. While 20-Day Moving Average VS Current Price shows “Sell” Signal.
TherapeuticsMD inc (NYSE:TXMD) lost -0.76 Percent and closed its previous trading session at $5.19. The stock traded with the average Volume of 3.21 Million at the end of last session.
TherapeuticsMD inc (NYSE:TXMD) has the Market Capitalization of 1.12 Billion. The Stock has its 52-week High of $7.66 and 52-Week Low of $4.34 and it touched its 52-week high on 06/08/18 and 52-Week Low on 11/03/17
The company reported its last earnings Actual EPS of $-0.15/share. While, the analyst predicted that the company could provide an EPS of $-0.12/share. Hence the difference between Predicted EPS and Actual EPS reported is $-0.03/share which shows an Earnings Surprise of -25 Percent.
Sell side analysts plays vital role in buying and selling a stock where 3 analysts rated TherapeuticsMD inc (NYSE:TXMD) as Buy, 0 analysts given Outperform signal, 0 reported Hold, and 0 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -14.24% where SMA50 and SMA200 are -19.64% and -11.8% respectively.
The company shows its Return on Assets (ROA) value of -62.6%. The Return on Equity (ROE) value stands at -80.7%. While it’s Return on Investment (ROI) value is -59.8%.
TherapeuticsMD inc (NYSE:TXMD) currently has a Weekly Volatility of 3.56% percent while its Monthly Volatility is at 4.23% percent. While talking about Performance of the Stock, TherapeuticsMD inc currently has a Weekly performance of -0.95%, monthly performance percentage is -22.54 percent, Quarterly performance is -13.21 percent, 6 months performance shows a percent value of -2.81% and Yearly Performance is -6.82 percent.
TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.